Anandamide and vanilloid TRPV1 receptors

By R. Ross. British Journal of Pharmacology, 2003

596 citations recorded by the source corpus.

Subfields: Endocrine and Autonomic Systems, Pharmacology, Sensory Systems

View Paper: https://www.semanticscholar.org/paper/a1d01e75e4538e6391e02a7046145d29afbf4d4d

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrine and Autonomic Systems

1. R. Pertwee

In Pharmacology

1. R. Pertwee
2. V. Di Marzo

In Sensory Systems

1. M. Delling
2. Ramsey Delling Clapham
3. I. S. Ramsey
4. D. Clapham
5. R. Pertwee

Citations in the corpus

• Pharmacological actions of cannabinoids. (2005, background): “It is now generally accepted that the endogenous CB1/CB2 receptor agonist, anandamide, and certain of its analogues are agonists for the TRPV1 receptor (reviewed in Howlett et al. 2002; Pertwee 2004a; Pertwee and Ross 2002; Ross 2003).”
• Cannabinoid pharmacology: the first 66 years (2006, background): “It is now generally accepted that, in contrast to 2- arachidonoyl glycerol and established non-eicosanoid cannabinoids, anandamide can activate not only CB1 and CB2 receptors but also vanilloid TRPV1 receptors (reviewed in Ross, 2003).”
• An introduction to TRP channels. (2006, background): “As for classically defined GPCRs, the apparent potency of TRP channel agonists will be sensitive to both channel number and the degree of cellular signal amplification that is effected subsequent to agonist binding (9).”